Board meeting held on 14th February, 2026 to consider, approve standalone and consolidated financial results for the quarter ended 31st December, 2025 along with limited review report given ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Hipolin Ltd's board approved unaudited standalone and consolidated financial results for Q3 FY26 and the nine months ended 31 December 2025, with a clean (unmodified) limited review report from auditor S D P M & Co. The company returned to a marginal profit of Rs 0.84 lakh in Q3 FY26, compared with a loss of Rs 56.85 lakh in Q3 FY25. However, revenue from operations fell sharply to Rs 376.12 lakh from Rs 503.73 lakh year-on-year, a drop of about 25%. Nine-month revenue declined steeply to Rs 1,034.88 lakh from Rs 1,741.54 lakh, while the nine-month net loss narrowed to Rs 76.82 lakh from Rs 91.31 lakh. Exceptional items of Rs 6.57 lakh were reported in the quarter.
The swing to a small quarterly profit is a modest positive for shareholders, but the steep year-on-year revenue decline and lingering nine-month loss suggest continued business weakness, which is likely to keep the stock under pressure.